Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.
D000818:Animals; D000937:Antigen-Antibody Reactions; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000276:immunology*; D002458:Cell Fractionation; D002460:Cell Line; D002462:Cell Membrane; D002464:Cell Migration Inhibition; D002852:Chromatography, Ion Exchange; D003601:Cytotoxicity Tests, Immunologic; D005455:Fluorescent Antibody Technique; D007106:Immune Sera / Q000494:pharmacology*; D008113:Liver Neoplasms / Q000139:chemically induced / Q000276:immunology*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010206:Papain; D051381:Rats; D012995:Solubility; D014184:Transplantation, Homologous; D014461:Ultracentrifugation
D007106:Immune Sera; D010206:Papain